Siteman | Strategic Alliance Partners

Latest from Siteman

Treatment Selection Becomes Complex Amid Growing Armamentarium in HER2+ Breast Cancer

November 24, 2020

Article

Nusayba Bagegni, MD, discusses prominent data that have emerged in early-stage and metastatic HER2-positive breast cancer.

Dr. Bagegni on the Safety Profile of T-DM1 in Early-Stage HER2+ Breast Cancer

November 12, 2020

Video

Nusayba Bagegni, MD, discusses the safety profile of ado-trastuzumab emtansine in early-stage HER2-positive breast cancer.

Breast Cancer: Chaired by Cynthia X. Ma, MD, PhD

October 20, 2020

Video

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.

Dr. Kahl on Remaining Challenges in Indolent Non-Hodgkin Lymphoma

September 17, 2020

Video

Brad S. Kahl, MD, discusses remaining challenges in the indolent non-Hodgkin lymphoma treatment landscape.

Dr. Wang-Gillam on Next Steps With Defactinib Combo in Pancreatic Ductal Adenocarcinoma

May 05, 2020

Video

Andrea Wang-Gillam, MD, PhD, discusses potential next steps with a novel combination regimen in pancreatic ductal adenocarcinoma.

Expert Explains Significance of Tazemetostat FDA Approval for Rare Sarcoma

April 23, 2020

Article

Brian Van Tine, MD, PhD, discusses what tazemetostat’s approval brings to the treatment landscape for patients with epithelioid sarcoma.